Why BGPT?
logo

Review papers with raw data transparency

Quickly verify claims by accessing the underlying experimental data and figures.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation



    DTINet paper (10.1038/s41467-017-00680-8): evidence-quality review status
    I can’t responsibly assess evidence quality (methods rigor, dataset provenance, baselines, ablation coverage, statistical validity, and reproducibility) from only the DOI string you provided—those details require the paper’s full text / figures / supplementary methods.
    What I can do now is: (1) cite the paper anchor, (2) outline a stringent evidence-quality checklist tailored to DTINet-style modeling, and (3) tell you exactly what to upload so I can produce a true, line-by-line critique grounded in the paper itself.
    Paper:



     Long Explanation



    Evidence-Quality Review (DTINet): what can/can’t be concluded yet
    Date context: May 02, 2026 • Source provided: DOI only • Result: partial review only
    Blocking limitation (critical)
    A rigorous “evidence quality” critique must verify what data were used, how splits were constructed, which baselines were compared, how statistical uncertainty was estimated, and what experiments were performed to test failure modes. Those specifics are not present in your prompt, so any attempt to score rigorously without the PDF/supplement would be speculative and therefore not truth-seeking.
    The only fully citable artifact I have from your message is the DOI record itself:
    Evidence-quality checklist (DTI ML papers)
    Use this checklist to map the paper’s claims to evidence strength. When you upload the PDF/supplement, I will fill each row with concrete, cited details from the text/figures.
    Evidence dimension What “strong” looks like What I will extract (from paper) Evidence weakness flags
    Data provenance & leakage Citable sources; explicit preprocessing; anti-leakage split protocol Exact dataset names, filters, and split definitions Train/test overlap via entities or time leakage
    Baselines & fairness Strong comparators; same features; same evaluation protocol Which baselines; whether tuned; metric parity Cherry-picked baselines; different protocols
    Metric validity Proper ranking + calibration reporting; CI/variance shown AUPR/AUROC/accuracy specifics + uncertainty reporting Only point estimates; no variance; improper negative sampling
    Ablations & attribution Component-wise ablations; interpretable drivers Ablation list; effect sizes; where performance comes from No ablations; performance “attributed” without tests
    Generalization tests Cross-dataset and/or cold-start settings Which OOD splits and what “cold” means operationally Same distribution only; entity overlap hidden
    Reproducibility package Code/data availability; hyperparameters; seeds Any public repository; appendix hyperparameters Missing seeds; closed source; underspecified preprocessing
    What I need from you to finish the real evidence-quality score
    Upload any of the following (more is better):
    • PDF of the paper
    • Supplementary Methods (often where split/leakage details live)
    • Any experiment tables/figures showing dataset splits, metrics, baselines, ablations
    • If you already have them: code repo link and dataset download links
    With the PDF, I will produce a concrete critique with (a) evidence-strength grading per claim, (b) failure-mode audit (leakage, negative sampling, baseline fairness), and (c) reproducibility score based on what’s actually provided.
    Next step: run an AI scientist agent (iterative extraction + critique)
    This will iteratively extract the paper’s methods/metrics and then evaluate evidence quality against the checklist above.


    Feedback:   

    Updated: May 02, 2026

    BGPT Paper Review



    Study Novelty

    10%

    Novelty cannot be estimated from DOI-only input; accurate novelty scoring requires paper claims and methodological specifics. DOI anchor only provided:



    Scientific Quality

    20%

    I cannot assess methodological quality without the paper’s full methods/results. Any numeric score would be guesswork; therefore this low provisional score reflects informational insufficiency rather than actual study performance. DOI anchor only:



    Study Generality

    30%

    Generalizability depends on how DTIs were split/tested (cold-start/entity-held-out vs random splits) and which external datasets were used—none of which are provided here. DOI anchor only:



    Study Usefulness

    40%

    Usefulness depends on model performance, robustness, and reproducibility. Without extracting results tables/ablation studies/code availability, usefulness can’t be responsibly scored. DOI anchor only:



    Study Reproducibility

    10%

    Reproducibility scoring requires checking code/data release, preprocessing determinism, seeds, and hyperparameter transparency—absent here. DOI anchor only:



    Explanatory Depth

    20%

    Explanatory depth (mechanistic/attribution claims) requires the paper’s model description and interpretability/evidence; not provided. DOI anchor only:

     Analysis Wizard



    Not applicable: the request is evidence-quality review, which requires the paper PDF/supplement rather than computational bioinformatics on provided datasets.



     Hypothesis Graveyard



    DTINet’s performance is primarily due to “true biochemical generalization” independent of split design—unlikely; without checking split leakage/negative sampling, this attribution can fail badly.


    DTINet is robust across datasets because the architecture is universally expressive—cannot be assumed; robustness must be verified by explicit cross-dataset testing and consistent evaluation protocol.

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT